<DOC>
	<DOCNO>NCT01332643</DOCNO>
	<brief_summary>This study evaluate effect single embryo transfer ( SET ) without array CGH evaluation complete chromosome complement blastocyst . Patients allocated random two group . The control group consist patient one embryo replace day 5 base morphological developmental characteristic , embryos reach blastocyst stage vitrify . The test group consist patient undergoing embryo biopsy blastocyst stage ( day 5 development , embryo freezing , analysis biopsied cell comprehensive chromosome analysis technique ( array Comparative Genome hybridization aCGH ) . Only chromosomally normal blastocyst replace thawed cycle . Inclusion exclusion criterion describe study population section .</brief_summary>
	<brief_title>Preimplantation Genetic Diagnosis ( PGD ) Array Comparative Genome Hybridization ( CGH ) Blastocyst Biopsy</brief_title>
	<detailed_description>Rational study : The goal study determine strategy employed Test group solve two major problem ART , one still low implantation rate woman advance maternal age , two frequent occurrence multiple pregnancy result solve first problem replace many embryo . Preimplantation Genetic Diagnosis ( PGD ) propose potential mean achieve goal , far , result day 3 biopsy FISH analysis 5-12 chromosome produce contradictory result , difference study explain technical difference ( Munne et al . 2010 ) . Three technical development recently occur change dramatically efficacy PGD . One , blastocyst laser assist biopsy , seem less detrimental cleavage stage biopsy ; Two , vitrification embryo allow blastocyst frozen little loss viability , three , chromosome comprehensive screening technique , array CGH ( Gutierrez-Mateo et al . 2011 ) allow detection chromosome abnormality . Preliminary data center indicate technique use , improvement prior technique CGH , result significant improvement implantation rate reduction miscarriage rate , thus justify use single embryo transfer set . Supportive Preliminary Research : In recent study , investigator observe 1.6 fold increase ( p &lt; 0.001 ) implantation rate aCGH apply blastocyst embryo ( Schoolcraft et al . 2010 ) . The test group use CGH , old less sensitive iteration technique use propose study - array CGH . Array CGH 6 megabase resolution screen 30 % DNA base ( compare 0.1 % SNP array ) . With array CGH false positive false negative rate 0 % biopsying blastocyst , 3 % biopsying day 3 embryo ( Gutierrez Mateo et al , 2011 ) . Based preliminary data , patient 5 day 3 embryo less 43 year age likely benefit PGD , since produce enough embryos enough normal embryos selection technique , like PGD could choose improve reproductive odds . Also PGD preliminary data show &lt; 10 % embryo demise implantation population 38 age ( expect would 28 % ) . Study Hypothesis The investigator foresee significant increase implantation rate Test group compare Control group . The investigator calculate 60 patient arm would need achieve significant increase implantation rate ( p &lt; 0.05 ) power 80 % , base comparative study investigator observe 1.6 fold increase implantation rate ( Schoolcraft et al . 2010 ) . Study population , intervention : see .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<criteria>Couples woman 3042 year age Follicle Stimulating Hormone ( FSH ) level &lt; 11IU/L day 3 cycle . TESA TESE patient Couples ' carrier chromosomal genetic disease Couples produce less eight antral follicle day 24 cycle Patients exclude produce blastocyst day 5</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Preimplantation Genetic Diagnosis</keyword>
	<keyword>recurrent pregnancy loss</keyword>
	<keyword>infertility</keyword>
	<keyword>genetic screening</keyword>
	<keyword>trisomy 21</keyword>
	<keyword>Down syndrome</keyword>
</DOC>